
Brian M. Gulledge
Examiner (ID: 5324, Phone: (571)270-5756 , Office: P/1612 )
| Most Active Art Unit | 1612 |
| Art Unit(s) | 1699, 1612, 1619 |
| Total Applications | 1214 |
| Issued Applications | 625 |
| Pending Applications | 102 |
| Abandoned Applications | 497 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18815841
[patent_doc_number] => 20230390180
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-12-07
[patent_title] => None
[patent_app_type] => utility
[patent_app_number] => 18/323774
[patent_app_country] => US
[patent_app_date] => 2023-05-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11186
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18323774
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/323774 | None | May 24, 2023 | Abandoned |
Array
(
[id] => 20577137
[patent_doc_number] => 12569371
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-03-10
[patent_title] => Sterilization of medical dressings with enhanced antimicrobial properties
[patent_app_type] => utility
[patent_app_number] => 18/198469
[patent_app_country] => US
[patent_app_date] => 2023-05-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 4
[patent_no_of_words] => 374
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 87
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18198469
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/198469 | Sterilization of medical dressings with enhanced antimicrobial properties | May 16, 2023 | Issued |
Array
(
[id] => 19798808
[patent_doc_number] => 20250064733
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-02-27
[patent_title] => USE OF PEG-BASED INTERPOLYMER COMPLEXES FOR IMPROVED SOLUBILIZATION F BCS CLASS II DRUGS
[patent_app_type] => utility
[patent_app_number] => 18/842870
[patent_app_country] => US
[patent_app_date] => 2023-05-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1618
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 59
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18842870
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/842870 | USE OF PEG-BASED INTERPOLYMER COMPLEXES FOR IMPROVED SOLUBILIZATION F BCS CLASS II DRUGS | May 16, 2023 | Pending |
Array
(
[id] => 20206192
[patent_doc_number] => 20250275912
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-09-04
[patent_title] => NOVEL COMPOSITION FOR IMPROVEMENT OF HAIR AND SCALP CONDITION
[patent_app_type] => utility
[patent_app_number] => 18/858779
[patent_app_country] => US
[patent_app_date] => 2023-04-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 0
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18858779
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/858779 | NOVEL COMPOSITION FOR IMPROVEMENT OF HAIR AND SCALP CONDITION | Apr 20, 2023 | Pending |
Array
(
[id] => 20031840
[patent_doc_number] => 20250170062
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-05-29
[patent_title] => NON-LINEAR PEGYLATED LIPID CONTAINING A TERTIARY AMINE AND APPLICATION THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/839059
[patent_app_country] => US
[patent_app_date] => 2023-04-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23627
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18839059
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/839059 | NON-LINEAR PEGYLATED LIPID CONTAINING A TERTIARY AMINE AND APPLICATION THEREOF | Apr 10, 2023 | Pending |
Array
(
[id] => 18535900
[patent_doc_number] => 20230240986
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-03
[patent_title] => INHALABLE RAPAMYCIN FORMULATION FOR TREATING AGE-RELATED CONDITIONS
[patent_app_type] => utility
[patent_app_number] => 18/132743
[patent_app_country] => US
[patent_app_date] => 2023-04-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25374
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18132743
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/132743 | INHALABLE RAPAMYCIN FORMULATION FOR TREATING AGE-RELATED CONDITIONS | Apr 9, 2023 | Abandoned |
Array
(
[id] => 20082960
[patent_doc_number] => 20250212896
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-07-03
[patent_title] => PROCESS FOR THE PREPARATION OF A HYDROLYZED EXTRACT OF NON-ANIMAL ORIGIN
[patent_app_type] => utility
[patent_app_number] => 18/850406
[patent_app_country] => US
[patent_app_date] => 2023-03-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 593
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 139
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18850406
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/850406 | PROCESS FOR THE PREPARATION OF A HYDROLYZED EXTRACT OF NON-ANIMAL ORIGIN | Mar 29, 2023 | Pending |
Array
(
[id] => 20039080
[patent_doc_number] => 20250177302
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-06-05
[patent_title] => LIPOSOME COMPOSITION AND LIPOSOME-CONTAINING PHARMACEUTICAL COMPOSITION
[patent_app_type] => utility
[patent_app_number] => 18/840179
[patent_app_country] => US
[patent_app_date] => 2023-03-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2996
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18840179
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/840179 | LIPOSOME COMPOSITION AND LIPOSOME-CONTAINING PHARMACEUTICAL COMPOSITION | Mar 28, 2023 | Pending |
Array
(
[id] => 21009731
[patent_doc_number] => 12746202
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-09-29
[patent_title] => Cationic lipid having disulfide bond, lipid membrane structure including same, nucleic acid introduction agent and pharmaceutical composition containing any one of same, method for introducing nucleic acid into cell or target cell, and method for producing cellular pharmaceutical
[patent_app_type] => utility
[patent_app_number] => 18/852405
[patent_app_country] => US
[patent_app_date] => 2023-03-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22345
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 196
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18852405
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/852405 | CATIONIC LIPID HAVING DISULFIDE BOND, LIPID MEMBRANE STRUCTURE INCLUDING SAME, NUCLEIC ACID INTRODUCTION AGENT AND PHARMACEUTICAL COMPOSITION CONTAINING ANY ONE OF SAME, METHOD FOR INTRODUCING NUCLEIC ACID INTO CELL OR TARGET CELL, AND METHOD FOR PRODUCING CELLULAR PHARMACEUTICAL | Mar 23, 2023 | Pending |
Array
(
[id] => 20371266
[patent_doc_number] => 12478681
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-11-25
[patent_title] => Non-activated, amorphous, pH neutral, two-part bedside-ready clay delivery system that treats pathogen infections in humans and animals
[patent_app_type] => utility
[patent_app_number] => 18/187224
[patent_app_country] => US
[patent_app_date] => 2023-03-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 5
[patent_no_of_words] => 11747
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 81
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18187224
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/187224 | Non-activated, amorphous, pH neutral, two-part bedside-ready clay delivery system that treats pathogen infections in humans and animals | Mar 20, 2023 | Issued |
Array
(
[id] => 20083612
[patent_doc_number] => 20250213548
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-07-03
[patent_title] => PHARMACEUTICAL COMPOSITIONS FOR IMPROVING ORAL BIOAVAILABILITY
[patent_app_type] => utility
[patent_app_number] => 18/847553
[patent_app_country] => US
[patent_app_date] => 2023-03-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18436
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -43
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18847553
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/847553 | PHARMACEUTICAL COMPOSITIONS FOR IMPROVING ORAL BIOAVAILABILITY | Mar 16, 2023 | Pending |
Array
(
[id] => 20048264
[patent_doc_number] => 20250186486
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-06-12
[patent_title] => POTENTIATION OF DURABLE ANTITUMOR IMMUNITY BY MULTIFACTORIAL IMMUNE MODULATION
[patent_app_type] => utility
[patent_app_number] => 18/843991
[patent_app_country] => US
[patent_app_date] => 2023-03-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15887
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -165
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18843991
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/843991 | POTENTIATION OF DURABLE ANTITUMOR IMMUNITY BY MULTIFACTORIAL IMMUNE MODULATION | Mar 16, 2023 | Pending |
Array
(
[id] => 20471976
[patent_doc_number] => 20260014194
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2026-01-15
[patent_title] => COMBINATIONS COMPRISING METAP2 INHIBITORS FOR THE TREATMENT OF CANCER
[patent_app_type] => utility
[patent_app_number] => 18/846365
[patent_app_country] => US
[patent_app_date] => 2023-03-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22208
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18846365
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/846365 | COMBINATIONS COMPRISING METAP2 INHIBITORS FOR THE TREATMENT OF CANCER | Mar 15, 2023 | Pending |
Array
(
[id] => 19860561
[patent_doc_number] => 20250099347
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-03-27
[patent_title] => ENCAPSULATED COMPOSITIONS
[patent_app_type] => utility
[patent_app_number] => 18/842208
[patent_app_country] => US
[patent_app_date] => 2023-03-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13163
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 73
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18842208
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/842208 | Encapsulated compositions | Mar 6, 2023 | Issued |
Array
(
[id] => 18495969
[patent_doc_number] => 20230218487
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-07-13
[patent_title] => Depilatory Wax Additive and Process
[patent_app_type] => utility
[patent_app_number] => 18/177407
[patent_app_country] => US
[patent_app_date] => 2023-03-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4177
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -3
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18177407
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/177407 | Depilatory wax additive and process | Mar 1, 2023 | Issued |
Array
(
[id] => 18449328
[patent_doc_number] => 20230190604
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-22
[patent_title] => DERMATOLOGIC/PERSONAL CARE CONCENTRATES
[patent_app_type] => utility
[patent_app_number] => 18/111196
[patent_app_country] => US
[patent_app_date] => 2023-02-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4302
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 55
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18111196
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/111196 | DERMATOLOGIC/PERSONAL CARE CONCENTRATES | Feb 16, 2023 | Pending |
Array
(
[id] => 19875737
[patent_doc_number] => 20250107994
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-04-03
[patent_title] => COMPOUND IN WHICH POLYGLYCEROL, FATTY ACID, AND DICARBOXYLIC ACID HAVE BEEN ESTERIFIED
[patent_app_type] => utility
[patent_app_number] => 18/844103
[patent_app_country] => US
[patent_app_date] => 2023-02-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5991
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -4
[patent_words_short_claim] => 119
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18844103
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/844103 | Compound in which polyglycerol, fatty acid, and dicarboxylic acid have been esterified | Feb 7, 2023 | Issued |
Array
(
[id] => 19889008
[patent_doc_number] => 20250114320
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-04-10
[patent_title] => MICROSPHERES FOR EXTENDED RELEASE OF FENOFIBRATE
[patent_app_type] => utility
[patent_app_number] => 18/836472
[patent_app_country] => US
[patent_app_date] => 2023-02-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10775
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18836472
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/836472 | MICROSPHERES FOR EXTENDED RELEASE OF FENOFIBRATE | Feb 6, 2023 | Pending |
Array
(
[id] => 20425248
[patent_doc_number] => 20250387335
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-12-25
[patent_title] => Pharmaceutical Compositions, and Preparation and Methods of Use Thereof
[patent_app_type] => utility
[patent_app_number] => 18/835417
[patent_app_country] => US
[patent_app_date] => 2023-02-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18685
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18835417
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/835417 | Pharmaceutical Compositions, and Preparation and Methods of Use Thereof | Feb 1, 2023 | Pending |
Array
(
[id] => 20039079
[patent_doc_number] => 20250177301
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-06-05
[patent_title] => TRIPLEX NANOPARTICLES
[patent_app_type] => utility
[patent_app_number] => 18/834513
[patent_app_country] => US
[patent_app_date] => 2023-01-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 41720
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18834513
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/834513 | TRIPLEX NANOPARTICLES | Jan 30, 2023 | Pending |